Your browser doesn't support javascript.
loading
Dysautonomia in anti-Hu paraneoplastic neurological syndromes.
Villagrán-García, Macarena; Farina, Antonio; Arzalluz-Luque, Joaquín; Campetella, Lucia; Muñiz-Castrillo, Sergio; Benaiteau, Marie; Peter, Elise; Dumez, Pauline; Wucher, Valentin; Dhairi, Maroua; Picard, Géraldine; Rafiq, Marie; Psimaras, Dimitri; Rogemond, Véronique; Joubert, Bastien; Honnorat, Jérôme.
Affiliation
  • Villagrán-García M; French Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, 59 Bd Pinel, 69677, Bron Cedex, France.
  • Farina A; MeLiS-UCBL-CNRS UMR 5284, INSERM U1314, University Claude Bernard Lyon 1, 69008, Lyon, France.
  • Arzalluz-Luque J; French Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, 59 Bd Pinel, 69677, Bron Cedex, France.
  • Campetella L; MeLiS-UCBL-CNRS UMR 5284, INSERM U1314, University Claude Bernard Lyon 1, 69008, Lyon, France.
  • Muñiz-Castrillo S; Department of Neuroscience, Psychology, Pharmacology and Child Health, University of Florence, 50139, Florence, Italy.
  • Benaiteau M; French Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, 59 Bd Pinel, 69677, Bron Cedex, France.
  • Peter E; Department of Neurology, Hospital Universitario Virgen Macarena, 41009, Seville, Spain.
  • Dumez P; French Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, 59 Bd Pinel, 69677, Bron Cedex, France.
  • Wucher V; French Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, 59 Bd Pinel, 69677, Bron Cedex, France.
  • Dhairi M; Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, CA, 94304, USA.
  • Picard G; French Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, 59 Bd Pinel, 69677, Bron Cedex, France.
  • Rafiq M; French Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, 59 Bd Pinel, 69677, Bron Cedex, France.
  • Psimaras D; MeLiS-UCBL-CNRS UMR 5284, INSERM U1314, University Claude Bernard Lyon 1, 69008, Lyon, France.
  • Rogemond V; French Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, 59 Bd Pinel, 69677, Bron Cedex, France.
  • Joubert B; MeLiS-UCBL-CNRS UMR 5284, INSERM U1314, University Claude Bernard Lyon 1, 69008, Lyon, France.
  • Honnorat J; French Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, 59 Bd Pinel, 69677, Bron Cedex, France.
J Neurol ; 271(6): 3359-3369, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38494470
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Dysautonomia has been associated with paraneoplastic neurological syndrome (PNS)-related mortality in anti-Hu PNS, but its frequency and spectrum remain ill-defined. We describe anti-Hu patients with dysautonomia, estimate its frequency, and compare them to patients without dysautonomia.

METHODS:

Patients with anti-Hu antibodies diagnosed in the study centre (1990-2022) were retrospectively reviewed; those with autonomic signs and symptoms were identified.

RESULTS:

Among 477 anti-Hu patients, 126 (26%) had dysautonomia (the only PNS manifestation in 7/126, 6%); gastrointestinal (82/126, 65%), cardiovascular (64/126, 51%), urogenital (24/126, 19%), pupillomotor/secretomotor (each, 11/126, 9%), and central hypoventilation (10/126, 8%). Patients with isolated CNS involvement less frequently had gastrointestinal dysautonomia than those with peripheral (alone or combined with CNS) involvement (7/23, 30% vs. 31/44, 70% vs. 37/52, 71%; P = 0.002); while more frequently central hypoventilation (7/23, 30% vs. 1/44, 2.3% vs. 2/52, 4%; P < 0.001) and/or cardiovascular alterations (18/23, 78% vs. 20/44, 45% vs. 26/52, 50%; P = 0.055). Median [95% CI] overall survival was not significantly different between patients with (37 [17; 91] months) or without dysautonomia (28 [22; 39] months; P = 0.78). Cardiovascular dysautonomia (HR 1.57, 95% CI [1.05; 2.36]; P = 0.030) and central hypoventilation (HR 3.51, 95% CI [1.54; 8.01]; P = 0.003) were associated with a higher risk of death, and secretomotor dysautonomia a lower risk (HR 0.28, 95% CI [0.09; 0.89]; P = 0.032). Patients with cardiovascular dysautonomia dying ≤ 1 year from clinical onset had severe CNS (21/27, 78%), frequently brainstem (13/27, 48%), involvement.

DISCUSSION:

Anti-Hu PNS dysautonomia is rarely isolated, frequently gastrointestinal, cardiovascular and urogenital. CNS dysfunction, particularly brainstem, associates with lethal cardiovascular alterations and central hypoventilation, while peripheral involvement preferentially associates with gastrointestinal or secretomotor dysautonomia, being the latest more indolent.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Paraneoplastic Syndromes, Nervous System / Primary Dysautonomias Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Neurol Year: 2024 Type: Article Affiliation country: France

Full text: 1 Database: MEDLINE Main subject: Paraneoplastic Syndromes, Nervous System / Primary Dysautonomias Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Neurol Year: 2024 Type: Article Affiliation country: France